Cite
HARVARD Citation
de Blank, P. et al. (2022). MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus. Neuro-oncology. 24 (11), pp. 1845-1856. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
de Blank, P. et al. (2022). MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus. Neuro-oncology. 24 (11), pp. 1845-1856. [Online].